Cannabis Law Report

FEBRUARY 15, 2022

Le Herbe releases new white paper on cannabis powder because education is key to accepting a healthy alternative to alcohol. They offer a standardized process for making cannabis powder, highlight instruments, and demand high quality data. the_art_and_science_of_cannabis_powder. Grillo, Founder, Le Herbe.

Research and Development 52

Research and Development Trichome Digestion Edibles 52

SpeedWeed

FEBRUARY 20, 2021

French hemp group – the Medical Cannabis and Wellness Hemp Union (SPC) – estimates these changes could transform French CBD into a €1bn industry by 2023. This comes as the country is launching a 3,000-patient medical cannabis trial, and scores of new CBD stores are opening following the crucial KanaVape judgement late last year.

Business 52

Business CBD Hemp Research and Development 52

Cannabis Law Report

JULY 2, 2021

Welcome to the Cannabis Freedom Alliance Monthly Newsletter! The Cannabis Freedom Alliance (CFA) will take this opportunity to provide you each month with relevant news, policy, and legislative updates on how CFA and its members are marching towards the goal of ending cannabis prohibition. Meet the Cannabis Freedom Alliance!

Policy 119

Policy Legislation Cannabis Legalization 119

Cannabis Law Report

NOVEMBER 26, 2019

Given the nascent nature of the cannabis industry—particularly here in Australia—it can be tough to separate the wheat from the chaff. Prescription numbers have also started to spike rapidly, with July alone seeing a 40% month on month increase in new patient approvals. After all, a good ship is useless without a great captain.

Research and Development 59

Research and Development Medicine Cannabis Cannabinoids 59

Cannabis Law Report

DECEMBER 21, 2021

Genomics test results allow practitioners and patients to set individualized, trackable goals around pharmacogenomics (PGx), cannabis DNA, nutrition DNA, and fitness DNA for personalized health and wellness. With instant screening test results, both patient and physician receive precious time to develop treatment plans.

Research and Development 52

Research and Development Supply Chain Data Business 52

MGC Pharma

FEBRUARY 15, 2018

What will unrestricted access to Medicinal Cannabis look like in Australia? A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals Right now in Australia, access to Cannabis-based treatments is heavily restricted. Australia is a vital player in the global Medicinal Cannabis game.

Access 100

Access Medicine Chronic Pain Research and Development 100

Cannabis Law Report

OCTOBER 17, 2019

As more countries legalize or decriminalize the cultivation, manufacture, sale, and use of cannabis, companies across a variety of industries are looking for opportunities to capitalize on this emerging market. This white paper offers a primer to the complex and confusing global cannabis industry as it stands today.

Law 40

Law Seed-To-Sale Hemp Recreational 40